Compounds > alpha-aminopyridine
Page last updated: 2024-08-21

alpha-aminopyridine and Supranuclear Palsy, Progressive

alpha-aminopyridine has been researched along with Supranuclear Palsy, Progressive in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Benedet, AL; Gauthier, S; Kang, MS; Massarweh, G; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Struyfs, H; Therriault, J1
Barkhausen, C; Blazhenets, G; Frings, L; Jost, WH; Meyer, PT; Rijntjes, M; Schröter, N; Weiller, C1
Blesa, R; Camacho, V; Fernández León, A; Lleó, A; López-Mora, DA1
Chen, SH; Hsiao, IT; Hsu, JL; Lin, KJ; Lu, CS; Okamura, N; Weng, YH; Yen, TC1
Comley, RA; Gauthier, S; Guiot, MC; Guo, Q; Harada, R; Kang, MS; Massarweh, G; Mathotaarachchi, S; Ng, KP; Okamura, N; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Therriault, J1
Arai, H; Funaki, Y; Furukawa, K; Furumoto, S; Harada, R; Hiraoka, K; Ishikawa, Y; Ishiki, A; Iwata, R; Kai, H; Kitamoto, T; Kudo, Y; Okamura, N; Sasano, H; Sato, N; Tashiro, M; Tomita, N; Totsune, T; Watanuki, S; Yanai, K1

Other Studies

6 other study(ies) available for alpha-aminopyridine and Supranuclear Palsy, Progressive

ArticleYear
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
    NeuroImage. Clinical, 2019, Volume: 24

    Topics: Aged; Aged, 80 and over; Aminopyridines; Benzofurans; Female; Humans; Hydrocarbons, Fluorinated; Indans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurofibrillary Tangles; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins

2019
Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:4

    Topics: Aged; Alzheimer Disease; Aminopyridines; Benzothiazoles; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins

2020
The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:5

    Topics: Aged; Aminopyridines; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Quinolines; Supranuclear Palsy, Progressive; tau Proteins

2020
    Scientific reports, 2020, 11-10, Volume: 10, Issue:1

    Topics: Aged; Aminopyridines; Brain; Case-Control Studies; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Quinolines; Sensitivity and Specificity; Supranuclear Palsy, Progressive

2020
Monoamine oxidase B inhibitor, selegiline, reduces
    Alzheimer's research & therapy, 2017, Mar-31, Volume: 9, Issue:1

    Topics: Aged; Alzheimer Disease; Aminopyridines; Autoradiography; Binding, Competitive; Brain; Cognitive Dysfunction; Drug Interactions; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Selegiline; Supranuclear Palsy, Progressive; tau Proteins

2017
Neuroimaging-pathological correlations of [
    Acta neuropathologica communications, 2018, 06-29, Volume: 6, Issue:1

    Topics: Aged; Aged, 80 and over; Aminopyridines; Aniline Compounds; Astrocytes; Autopsy; Autoradiography; Correlation of Data; Female; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Picolinic Acids; Positron-Emission Tomography; Quinolines; Supranuclear Palsy, Progressive; tau Proteins; Thiazoles

2018